AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Studies Show ACTOS(R) (pioglitazone HCl) Has Positive Effects on Various Components of Dyslipidemia.
ORLANDO, Fla., June 5 /PRNewswire/ -- Two clinical studies presented at the American Diabetes Association's (ADA) Scientific Sessions showed that ACTOS(R) (pioglitazone HCl) has favorable effects on dyslipidemia (low HDL-C levels, high triglycerides and high levels of small, dense LDL-C) and insulin resistance. Dyslipidemia and insulin resistance are two key components of the metabolic syndrome, which is often exhibited in patients with type 2 diabetes.
"When you put the pieces together, these separate findings are very exciting because they show that ACTOS therapy can provide benefits extending beyond improvements in glucose levels," said Mehmood Khan, M.D., F.A.C.E., senior vice president for medical and scientific affairs, Takeda Pharmaceuticals. "These studies showed that ACTOS can affect certain components of the metabolic syndrome, each of which must be managed when treating people with type 2 diabetes. We now have reason to believe that, when a physician prescribes ACTOS for type 2…
- ACTOS(R) is Today's Most Prescribed Insulin Resistance Reducer for Type 2...
- Press release article from: PR Newswire October 29, 2002 700+ words
...than 2.9 million patients have used ACTOS. ACTOS is also the leading insulin resistance reducer among U.S. endocrinologists...cholesterol disorders, obesity and insulin resistance. ACTOS is sold in more than 40 countries worldwide...
- Studies show that ACTOS has positive effects on dyslipidemia, insulin...
- Newspaper article from: Diabetes Week July 5, 2004 700+ words
...Sessions showed that ACTOS (pioglitazone HCl...on dyslipidemia and insulin resistance. Dyslipidemia and...or a combination of ACTOS with these two agents...hyperglycemia by addressing insulin resistance, ACTOS alone, or in combination...
- Incyte Genomics and the University of Cambridge Report New Cause of Severe...
- Press release article from: Business Wire July 15, 2002 700+ words
...Inheritance of Severe Insulin Resistance in a Human Pedigree...inherited form of severe insulin resistance. The finding confirms...sensitizing drugs such as ACTOS and AVANDIA, reported...underlie some forms of insulin-resistance by Incyte Genomics...
- ACTOS (PIOGLITAZONE HCL) DEMONSTRATED AS EFFECTIVE COMBINATION THERAPY WITH...
- Press release article from: PR Newswire September 19, 2000 700+ words
...trial that combined ACTOS with sulfonylurea treatment...demonstrated a reduction in the insulin resistance process. ACTOS recently received a...patients demonstrated that ACTOS significantly reduced insulin resistance and improved beta cell...
- ACTOS(R) Improves Glucose Control and Lipid Profiles in People With Type 2...
- Press release article from: PR Newswire May 31, 2002 700+ words
...exhibited improved results when ACTOS(R) (pioglitazone HCl) was...the clinical study show that ACTOS, used in combination with a...the preceding 90 - 120 days. ACTOS is an insulin resistance reducer, and the only thiazolidinedione...
- Actos effective in people with type 2 diabetes who use insulin.
- Newspaper article from: Diabetes Week July 22, 2002 700+ words
...exhibited improved results when Actos (pioglitazone HCl) was added...the clinical study show that Actos, used in combination with a...the preceding 90-120 days. Actos is an insulin resistance reducer, and the only thiazolidinedione...
- 25 Million ACTOS(R) Prescriptions Translates to Millions of Patients Helped;...
- Press release article from: PR Newswire August 25, 2003 700+ words
...of time." ACTOS was approved...surrounding the role insulin resistance plays in diabetes...TZDs such as ACTOS are known as insulin resistance reducers because...Americans have insulin resistance, which seems...complications. ACTOS is taken once...
- 25 Million Actos prescriptions written.
- Newspaper article from: Health & Medicine Week September 22, 2003 700+ words
...very proud of what Actos has achieved in a short amount of time." Actos was approved in July...surrounding the role insulin resistance plays in diabetes...years. TZDs such as Actos are known as insulin resistance reducers because...
- Additional Actos indication for Takeda.(Clinical report)
- Newspaper article from: Pharma Marketletter March 30, 2009 700+ words
...therapy with biguanides, for its Actos (pioglitazone hydrochloride...monotherapy was compared with Actos plus biguanides concomitant...increasing the risk of hypoglycemia. Actos directly targets insulin resistance by improving sensitivity to...
- Takeda Pharmaceutical Wins Patent Infringement Case on ACTOS in US.
- Magazine article from: JCNN News Summaries February 24, 2006 700+ words
...cannot approve any generic version of ACTOS until 2011, when Takeda's patent...Pharmaceutical retains several patents regarding ACTOS and its use, which are valid until 2016. ACTOS is an insulin resistance reducer for type 2 diabetes. Copyright...
Source: HighBeam Research, Studies Show ACTOS(R) (pioglitazone HCl) Has Positive Effects on...
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
